Robuta

https://innovate.research.ufl.edu/oragenics-inc-announces-completion-of-enrollment-of-its-phase-2-clinical-trial-for-ag013-in-oral-mucositis/ Oragenics, Inc. Announces Completion of Enrollment of Its Phase 2 Clinical Trial for AG013 in Oral...